Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
accesso Technology Group is a global provider of technology solutions for the leisure, entertainment, and cultural markets, as well as healthcare hospitality. The company specializes in virtual queuing, ticketing, and guest experience management, serving over 1,000 venues worldwide including theme parks, ski resorts, and stadiums. Through its 'The Experience Engine' (TE2) platform, accesso provides patient engagement and flow management solutions for the healthcare sector, helping hospitals and clinics improve the patient journey. Publicly traded on the London Stock Exchange (AIM: ACSO), the company recently expanded its capabilities into AI and data analytics with the acquisition of Dexibit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on accesso Technology Group.